Home › Insys CEO Babich resigns, drugmaker tops 3Q expectations
 

Keywords :   


Insys CEO Babich resigns, drugmaker tops 3Q expectations

2015-11-05 19:25:14| Biotech - Topix.net

Michael L. Babich has resigned as president and CEO of Insys Therapeutics, a specialty drugmaker under investigation over sales of its powerful painkiller Subsys. Shares of the Chandler, Arizona, company jumped almost 10 percent Thursday morning as the company also announced third-quarter earnings that trumped analyst expectations and said it was buying back some stock.

Tags: ceo expectations tops resigns

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
More »